FindMyKOL

David Wirta, MD

Enriched profile

Medical Director, Eye Research Foundation, Inc. · Eye Research Foundation

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Newport Beach, CA · West · United StatesSpecialtyOphthalmologyFocusOcular Surface and Contact Lens+4
Active KOLFindMyKOL type: EliteLatest publication2021Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

David Wirta is Medical Director, Eye Research Foundation, Inc. at Eye Research Foundation. OpenAlex indexes 69 publications with 1,938 citations (h-index 24); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 23 Oct 2026

Overview

Updated 25 Oct 2026

David Wirta, MD, is Medical Director, Eye Research Foundation, Inc.. The public record shows 69 publications with 1,938 citations (h-index 24), centered on Ocular Surface and Contact Lens, Glaucoma and retinal disorders, Drug-Induced Ocular Toxicity. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 15 companies.

  • Most recent indexed publication: 2021 · Therapeutic delivery
  • Top research focus: Ocular Surface and Contact Lens
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 15 companies

Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Glaucoma3 trialsHypertension3 trialsOcular Hypertension3 trialsComa3 trialsDry Eye / Uveitis1 trialDry Eye Syndromes1 trialBlepharitis1 trial

Research focus

OpenAlex concept fingerprint
Ocular Surface and Contact LensGlaucoma and retinal disordersDrug-Induced Ocular ToxicityAdvanced Drug Delivery SystemsSalivary Gland Disorders and Functions

Drugs & molecules

across trials, industry payments and publications
Vevyegeneric · CyclosporineClinical trials—Industry payments2Publications3Tyrvayageneric · VareniclineClinical trials—Industry payments2Publications2Tryptyrgeneric · AcoltremonClinical trials—Industry payments10Publications—Eysuvisgeneric · Loteprednol etabonateClinical trials—Industry payments3Publications—Botoxgeneric · Botulinum toxin type AClinical trials—Industry payments2Publications—Ryzumvigeneric · PhentolamineClinical trials—Industry payments2Publications—Acthargeneric · CorticotropinClinical trials—Industry payments1Publications—Miebogeneric · PerfluorohexyloctaneClinical trials—Industry payments1Publications—Tepezzageneric · TeprotumumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Alcon Vision LLCClinical trials—Industry payments20Glaukos CorporationClinical trials—Industry payments10Abbvie Inc.Clinical trials—Industry payments8Allergan, Inc.Clinical trials—Industry payments4Alcon Research LLCClinical trials—Industry payments3Oyster Point Pharma, Inc.Clinical trials—Industry payments3Bausch & Lomb Americas Inc.Clinical trials—Industry payments2Aerie Pharmaceuticals, Inc.Clinical trials—Industry payments1Bausch & Lomb IncorporatedClinical trials1Industry payments—BRIM Biotechnology Inc.Clinical trials1Industry payments—Dompe US, Inc.Clinical trials—Industry payments1Harrow Eye, LLCClinical trials—Industry payments1Horizon Therapeutics plcClinical trials—Industry payments1JeniVision, Inc.Clinical trials1Industry payments—Kowa Research Institute, Inc.Clinical trials—Industry payments1Mallinckrodt Hospital Products Inc.Clinical trials—Industry payments1Tarsus Pharmaceuticals, Inc.Clinical trials1Industry payments—Thea Pharma Inc.Clinical trials—Industry payments1YS Life Science Co., Ltd.Clinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
69publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

1,938citations

Total citations across indexed works.

24h-index

Hirsch index (OpenAlex). i10-index 41.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
15companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 25 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

All 5 trial records: search, sort and filter.Explore →

Industry payments

Updated 25 Oct 2026

15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 23 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 25 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Most-cited works

by citation count (OpenAlex)
  1. 01
    Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert
    Article116 citations2016
    doi.org ↗
  2. 02
    Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
    Article106 citations2019
    doi.org ↗
  3. 03
    Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease
    Article104 citations2021
    doi.org ↗
  4. 04
    NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction
    Article100 citations2022
    doi.org ↗
  5. 05
    A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease
    Article88 citations2019
    doi.org ↗
All 69 cited works: search, sort and filter.Explore →

Network

Updated 25 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jason Bacharach9Kenneth N. Sall8Sonja Krösser6James H. Peace6Shérif M. El-Harazi6William C. Christie6Robert John Smyth-Medina6Michael R. Robinson6Michael S. Korenfeld5Eugene B. McLaurin5George W Ousler5Harvey B. Dubiner4Gary W. Jerkins4Joseph Tauber4Douglas G. Day4Charles B. Slonim4Paul M Karpecki4Thomas R. Walters3Marina Bejanian3Carol Aune3Alice S. Meides3Mark J Jaros3Earl Randy Craven3Matthew Paul3Bruce Segal3Shane R. Kannarr3Blair E. Boehmer3Robert Benza3Shane Foster3Joseph B. Ciolino3Sung Wook Lee3James D. Paauw3Bernard R. Perez2Michael E. Tepedino2Navin H Tekwani2Christopher Lin2Kavita Dhamdhere2Edward J. Meier2James D. Branch2Jing‐He Yan2

Online presence

Updated 25 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/david-wirta-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 25 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.